World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   7731 records for 1303 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingISRCTN87465420
Quality of adherence to guideline recommendations for life-saving treatment in heart failure: an international survey
07/05/2015
Not recruitingNCT02425644
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
21/04/2015
RecruitingNCT02423369
Cerebral Oxymetry and Neuronal Markers in Newborns and Infants Undergoing Surgery
17/04/2015
Not recruitingNCT02410343
Study of TV-1106 in Growth Hormone-Deficient Adults
30/03/2015
Not recruitingNCT02410356
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
30/03/2015
Not RecruitingCTRI/2015/03/005597
To compare the effect of Tiotropium 5 ug and Olodaterol 5 ug in fixed dose combination over Tiotropium 5 ug in reducing Moderate to severe worsening of a disease in patients with severe to very severe Chronic Obstructive Pulmonary disease
02-03-2015
AuthorisedEUCTR2014-005241-45-FI
A Phase III Study of Pembrolizumab in Subjects with Gastric Cancer 20/02/2015
AuthorisedEUCTR2014-003824-36-LT
A Phase III study to assess whether etrolizumab is a safe and effective treatment for patients with moderately to severely active Crohn's disease
Recruitment statusMain IDPublic titleDate of registration
RecruitingNCT02394028A Study of the Safety and Efficacy of Etrolizumab in Patients With Moderately to Severely Active Crohn's Disease27/02/2015
18/02/2015
AuthorisedEUCTR2014-003855-76-LT
An Open-Label Extension Study to assess the long-term safety and effective of etrolizumab treatment for patients with moderately to severely active Crohn's disease
Recruitment statusMain IDPublic titleDate of registration
Not recruitingNCT02403323Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA2914426/03/2015
18/02/2015
Not recruitingNCT02375971
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
18/02/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history